{"id":"W3090413519","doi":"10.1001/jamaoncol.2020.4564","title":"Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1212,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Tolerability; Internal medicine; Sorafenib; Hepatocellular carcinoma; Adverse effect; Randomized controlled trial; Surgery; Gastroenterology; Oncology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001102628,0.0003067554,0.0009543969,0.0001275571,0.00004889431,0.000009243133,0.00009365212,0.0002230116,0.00005568265],"category_scores_gemma":[0.00006113968,0.0002221654,0.000063466,0.0004487536,0.0001864194,0.0001154158,0.00005623144,0.0002813768,0.000008907393],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002892873,"about_ca_system_score_gemma":0.0003720966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001446771,"about_ca_topic_score_gemma":0.00005004143,"domain_scores_codex":[0.998207,0.0001603407,0.0004523515,0.0005227741,0.0002614518,0.0003960505],"domain_scores_gemma":[0.99891,0.0001331689,0.0002087807,0.0002770147,0.0001723989,0.0002986274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03483114,0.0006886204,0.9416983,0.0001980822,0.0001562057,0.0006551055,0.001329719,0.000006015737,0.0002675622,0.00001865006,0.00004138757,0.02010917],"study_design_scores_gemma":[0.09243507,0.02387923,0.8758689,0.0001929431,0.0004697821,0.00003343372,0.0001559943,0.001917701,0.002480461,0.000002343946,0.002288205,0.0002759427],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947886,0.0006169438,0.00002658973,0.001066659,0.00001525949,0.002404269,0.0000178839,0.00005506717,0.001008653],"genre_scores_gemma":[0.9980942,0.00006523076,0.001118808,0.0003095015,0.00003762009,0.00008594119,0.0001848283,0.00004931338,0.00005454699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06582944,"threshold_uncertainty_score":0.905964,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.023995485520902,"score_gpt":0.2317533058969982,"score_spread":0.2077578203760962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}